Abstract
Human endothelial cells (ECs) and pericytes are of great interest for research on vascular development and disease, as well as for future therapy. This protocol describes the efficient generation of ECs and pericytes from human pluripotent stem cells (hPSCs) under defined conditions. Essential steps for hPSC culture, differentiation, isolation and functional characterization of ECs and pericytes are described. Substantial numbers of both cell types can be derived in only 2–3 weeks: this involves differentiation (10 d), isolation (1 d) and 4 or 10 d of expansion of ECs and pericytes, respectively. We also describe two assays for functional evaluation of hPSC-derived ECs: (i) primary vascular plexus formation upon coculture with hPSC-derived pericytes and (ii) incorporation in the vasculature of zebrafish xenografts in vivo. These assays can be used to test the quality and drug sensitivity of hPSC-derived ECs and model vascular diseases with patient-derived hPSCs.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Generation of multilineage liver organoids with luminal vasculature and bile ducts from human pluripotent stem cells via modulation of Notch signaling
Stem Cell Research & Therapy Open Access 03 February 2023
-
Identification of stable housekeeping genes for induced pluripotent stem cells and -derived endothelial cells for drug testing
Scientific Reports Open Access 28 September 2022
-
Advances in cell therapies using stem cells/progenitors as a novel approach for neurovascular repair of the diabetic retina
Stem Cell Research & Therapy Open Access 30 July 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout







References
Thomson, J.A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147 (1998).
Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).
Chambers, S.M. et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275–280 (2009).
Touboul, T. et al. Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology 51, 1754–1765 (2010).
Green, M.D. et al. Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells. Nat. Biotechnol. 29, 267–272 (2011).
Spence, J.R. et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470, 105–109 (2011).
Elliott, D.A. et al. NKX2-5eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat. Methods 8, 1037–1040 (2011).
Dubois, N.C. et al. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat. Biotechnol. 29, 1011–1018 (2011).
Huang, S.X.L. et al. efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat. Biotechnol. 1–11 (2013).
Lancaster, M.A. et al. Cerebral organoids model human brain development and microcephaly. Nature 501, 373–379 (2013).
Ingram, D.A. et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104, 2752–2760 (2004).
Yoder, M.C. et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109, 1801–1809 (2007).
Armulik, A., Genové, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 21, 193–215 (2011).
Winkler, E.A., Bell, R.D. & Zlokovic, B.V. Central nervous system pericytes in health and disease. Nat. Neurosci. 14, 1398–1405 (2011).
Lebrin, F. et al. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat. Med. 16, 420–428 (2010).
Chintalgattu, V. et al. Coronary microvascular pericytes are the cellular target of sunitinib malate–induced cardiotoxicity. Sci. Transl. Med. 5, 187ra69 (2013).
Crisan, M. et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301–313 (2008).
Bianco, P. et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat. Med. 19, 35–42 (2013).
Frenette, P.S., Pinho, S., Lucas, D. & Scheiermann, C. Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu. Rev. Immunol. 31, 285–316 (2013).
Orlova, V.V. et al. Functionality of endothelial cells and pericytes from human pluripotent stem cells demonstrated in cultured vascular plexus and zebrafish xenografts. Arterioscler. Thromb. Vasc. Biol. 34, 177–186 (2014).
Levenberg, S. Endothelial cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 99, 4391–4396 (2002).
Dar, A. et al. Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb. Circulation 125, 87–99 (2012).
Choi, K.-D. et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27, 559–567 (2009).
Nourse, M.B. et al. VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler. Thromb. Vasc. Biol. 30, 80–89 (2009).
Adams, W.J. et al. Stem cell reports. Stem Cell Rep. 1, 105–113 (2013).
Vodyanik, M.A. et al. A mesoderm-derived precursor for mesenchymal stem and endothelial cells. Cell Stem Cell 7, 718–729 (2010).
Kusuma, S. et al. Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix. Proc. Natl. Acad. Sci. USA 110, 12601–12606 (2013).
James, D. et al. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFβ inhibition is Id1 dependent. Nat. Biotechnol. 28, 161–166 (2010).
Samuel, R. et al. Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells. Proc. Natl. Acad. Sci. USA 110, 12774–12779 (2013).
Park, T.S. et al. Vascular progenitors from cord blood–derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculature. Circulation 129, 359–372 (2014).
White, M.P. et al. Limited gene expression variation in human embryonic stem cell and induced pluripotent stem cell-derived endothelial cells. Stem Cells 31, 92–103 (2012).
Costa, M. et al. Derivation of endothelial cells from human embryonic stem cells in fully defined medium enables identification of lysophosphatidic acid and platelet activating factor as regulators of eNOS localization. Stem Cell Res. 10, 103–117 (2013).
Lippmann, E.S. et al. Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Nat. Biotechnol. 30, 783–791 (2012).
Cheung, C., Bernardo, A.S., Trotter, M.W.B., Pedersen, R.A. & Sinha, S. Generation of human vascular smooth muscle subtypes provides insight into embryological origin–dependent disease susceptibility. Nat. Biotechnol. 30, 165–173 (2012).
Ng, E.S., Davis, R., Stanley, E.G. & Elefanty, A.G. A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies. Nat. Protoc. 3, 768–776 (2008).
Lian, X. et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl. Acad. Sci. USA 109, E1848–E1857 (2012).
Evensen, L., Micklem, D.R., Link, W. & Lorens, J.B. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery. Cytometry A 77, 41–51 (2010).
Evensen, L., Link, W. & Lorens, J.B. Image-based high-throughput screening for inhibitors of angiogenesis. Methods Mol. Biol. 931, 139–151 (2013).
Evensen, L. et al. Mural cell associated VEGF is required for organotypic vessel formation. PLoS ONE 4, e5798 (2009).
Zudaire, E., Gambardella, L., Kurcz, C. & Vermeren, S. A computational tool for quantitative analysis of vascular networks. PLoS ONE 6, e27385 (2011).
Jones, T.R. et al. CellProfiler Analyst: data exploration and analysis software for complex image-based screens. BMC Bioinformatics 9, 482 (2008).
Stoletov, K. & Klemke, R. Catch of the day: zebrafish as a human cancer model. Oncogene 27, 4509–4520 (2008).
Goessling, W., North, T.E. & Zon, L.I. New waves of discovery: modeling cancer in zebrafish. J. Clin. Oncol. 25, 2473–2479 (2007).
Zon, L.I. & Peterson, R.T. In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 4, 35–44 (2005).
Isogai, S., Lawson, N.D., Torrealday, S., Horiguchi, M. & Weinstein, B.M. Angiogenic network formation in the developing vertebrate trunk. Development 130, 5281–5290 (2003).
Naber, H.P.H., Drabsch, Y., Snaar-Jagalska, B.E., ten Dijke, P. & van Laar, T. Snail and Slug, key regulators of TGF-β–induced EMT, are sufficient for the induction of single-cell invasion. Biochem. Biophys. Res. Commun. 435, 58–63 (2013).
Zhang, L. et al. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis. Mol. Cell 51, 559–572 (2013).
Zhang, L. et al. USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. Nat. Cell Biol. 14, 717–726 (2012).
He, S. et al. Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model. J. Pathol. 227, 431–445 (2012).
Ghotra, V.P.S. et al. Automated whole-animal bio-imaging assay for human cancer dissemination. PLoS ONE 7, e31281 (2012).
van de Stolpe, A. et al. Human embryonic stem cells: towards therapies for cardiac disease. Derivation of a Dutch human embryonic stem cell line. Reprod. BioMed. Online 11, 476–485 (2005).
Dambrot, C. et al. Polycistronic lentivirus induced pluripotent stem cells from skin biopsies after long term storage, blood outgrowth endothelial cells and cells from milk teeth. Differentiation 85, 101–109 (2013).
Davis, R.P. et al. A protocol for removal of antibiotic resistance cassettes from human embryonic stem cells genetically modified by homologous recombination or transgenesis. Nat. Protoc. 3, 1550–1558 (2008).
Westerfield, M. The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio) (4th ed.) (University of Oregon Press, 2007).
Rosol, T.J., Tannehill-Gregg, S.H., Corn, S., Schneider, A. & McCauley, L.K. Animal models of bone metastasis. Cancer Treat. Res. 118, 47–81 (2004).
Acknowledgements
We thank C. Freund (Department of Anatomy and Embryology and human iPS core facility, LUMC) for the establishment of the hPSC cultures, and D. Ward-van Oostwaard (Department of Anatomy and Embryology, LUMC) and S. van de Pas (human iPS core facility, LUMC) for their excellent technical assistance. We also thank J. Wiegant and A. Boonzaier-van der Laan (Department of Molecular Cell Biology, LUMC) for assistance with the imaging and confocal microscopy. We acknowledge K. Iwata (OSI Pharmaceuticals) for providing TGF-β3. The work was supported by the LUMC Gisela Thier Fellowship (V.V.O.); by the EU's Seventh Framework Programme for research, technical development and demonstration under grant agreement no. 602423 (Plurimes) (V.V.O. and F.E.v.d.H.); by the SWORO Foundation for Research on HHT (V.V.O. and F.E.v.d.H.); by the LeDucq VasculoMorph Transatlantic Consortium (P.t.D.); and the Netherlands Institute of Regenerative Medicine and the Netherlands Heart Foundation (2008B106; C.L.M.).
Author information
Authors and Affiliations
Contributions
V.V.O. designed the protocol, supervised the project, wrote the manuscript, established the monolayer differentiation, performed isolation and expansion of ECs and pericytes, performed the coculture experiment and performed all of the cell experiments. F.E.v.d.H. performed all of the cell experiments and wrote part of the protocol. S.P.-R. characterized the monolayer differentiation, performed the coculture experiments and developed the pipeline for the quantification of the vascular sprouts with CellProfiler. Y.D. performed zebrafish xenotransplantation experiments and wrote the zebrafish protocol. P.t.D. supervised the project and edited the manuscript. C.L.M. designed the protocol, supervised the project and wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Orlova, V., van den Hil, F., Petrus-Reurer, S. et al. Generation, expansion and functional analysis of endothelial cells and pericytes derived from human pluripotent stem cells. Nat Protoc 9, 1514–1531 (2014). https://doi.org/10.1038/nprot.2014.102
Published:
Issue Date:
DOI: https://doi.org/10.1038/nprot.2014.102
This article is cited by
-
Generation of multilineage liver organoids with luminal vasculature and bile ducts from human pluripotent stem cells via modulation of Notch signaling
Stem Cell Research & Therapy (2023)
-
3D human induced pluripotent stem cell–derived bioengineered skeletal muscles for tissue, disease and therapy modeling
Nature Protocols (2023)
-
3D vascularized eye tissue models age-related macular degeneration
Nature Methods (2023)
-
Bioprinted 3D outer retina barrier uncovers RPE-dependent choroidal phenotype in advanced macular degeneration
Nature Methods (2023)
-
Advances in cell therapies using stem cells/progenitors as a novel approach for neurovascular repair of the diabetic retina
Stem Cell Research & Therapy (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.